Chenguang Biotech Group Co Ltd
SZSE:300138
Intrinsic Value
Chenguang Biotech Group Co., Ltd. engages in natural plant extractions. [ Read More ]
The intrinsic value of one
Chenguang Biotech Group Co Ltd
stock under the Base Case scenario is
23.89
CNY.
Compared to the current market price of 9.77 CNY,
Chenguang Biotech Group Co Ltd
is
Undervalued by 59%.
Chenguang Biotech Group Co Ltd's market capitalization is 5.2B CNY.
Chenguang Biotech Group Co Ltd stock price is 9.77 CNY.
Chenguang Biotech Group Co Ltd stock price (9.77 CNY) is 59% less than its Intrinsic Value (23.89 CNY).
Chenguang Biotech Group Co Ltd stock price (9.77 CNY) is 52% less than its DCF Value (20.54 CNY). Open DCF Valuation
Chenguang Biotech Group Co Ltd stock price (9.77 CNY) is 64% less than its Relative Value (27.25 CNY). Open Relative Valuation
Chenguang Biotech Group Co Ltd has upside potential of 81% compared to the average analyst price target.
Open Wall St Estimates
Chenguang Biotech Group Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 10%.
Chenguang Biotech Group Co Ltd's Revenue has grown by 3% over the past 12 months.
Chenguang Biotech Group Co Ltd's ROE (Return on Equity) has increased in the last 3 years from 13% to 15%.
Chenguang Biotech Group Co Ltd's ROIC (Return on Invested Capital) has increased in the last 3 years from 8% to 10%.
Chenguang Biotech Group Co Ltd has positive three-year average ROIC (Return on Invested Capital): 9%. The company is efficient at using invested capital to generate operating income.
Chenguang Biotech Group Co Ltd has positive Operating Income for the last twelve months.
Chenguang Biotech Group Co Ltd has positive Gross Profit for the last twelve months.
Chenguang Biotech Group Co Ltd has negative Free Cash Flow for the last twelve months.
Chenguang Biotech Group Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 15%.
Chenguang Biotech Group Co Ltd has positive Net Income for the last twelve months.
Chenguang Biotech Group Co Ltd has positive three-year average ROE (Return on Equity): 14%. The company is efficient at transforming stockholders' equity into net income.
Chenguang Biotech Group Co Ltd has positive Net Debt. This means that the company has more debt (3B CNY) than cash and short-term investments (2B CNY).
Chenguang Biotech Group Co Ltd's Revenue is forecast to grow at a rate of 14% per year over the next 3 years.
Chenguang Biotech Group Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.8.
Chenguang Biotech Group Co Ltd's short-term assets (5B CNY) exceed its short-term liabilties (3B CNY).
Chenguang Biotech Group Co Ltd's Revenue has been growing by an exceptional 22% per year for the last 3 years.
Chenguang Biotech Group Co Ltd's long-term assets (7B CNY) exceed its long-term liabilties (4B CNY).
Chenguang Biotech Group Co Ltd's Altman Z-Score is very high and is equal to 3.06.
Valuation Backtest
Chenguang Biotech Group Co Ltd
Run backtest to discover the historical profit from buying and selling
Chenguang Biotech Group Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Chenguang Biotech Group Co Ltd
Balance Sheet Decomposition
Chenguang Biotech Group Co Ltd
| Current Assets | 5.3B |
| Cash & Short-Term Investments | 2.4B |
| Receivables | 399.5m |
| Other Current Assets | 2.5B |
| Non-Current Assets | 2.1B |
| Long-Term Investments | 102.4m |
| PP&E | 1.7B |
| Intangibles | 321.7m |
| Other Non-Current Assets | 61.3m |
| Current Liabilities | 3.3B |
| Accounts Payable | 40.8m |
| Accrued Liabilities | 109.7m |
| Short-Term Debt | 2.4B |
| Other Current Liabilities | 756.5m |
| Non-Current Liabilities | 672.6m |
| Long-Term Debt | 418.7m |
| Other Non-Current Liabilities | 253.8m |
Earnings Waterfall
Chenguang Biotech Group Co Ltd
|
Revenue
|
6.7B
CNY
|
|
Cost of Revenue
|
-5.8B
CNY
|
|
Gross Profit
|
840.9m
CNY
|
|
Operating Expenses
|
-290.1m
CNY
|
|
Operating Income
|
550.8m
CNY
|
|
Other Expenses
|
-55.2m
CNY
|
|
Net Income
|
495.6m
CNY
|
Free Cash Flow Analysis
Chenguang Biotech Group Co Ltd
Profitability Score
Profitability Due Diligence
Chenguang Biotech Group Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Chenguang Biotech Group Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Chenguang Biotech Group Co Ltd's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Score
Chenguang Biotech Group Co Ltd's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Chenguang Biotech Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
Chenguang Biotech Group Co Ltd
is 17.66 CNY
with a low forecast of 10.45 CNY and a high forecast of 27.3 CNY.
Shareholder Return
Price
Chenguang Biotech Group Co Ltd
| Average Annual Return | 44.36% |
| Standard Deviation of Annual Returns | 81.98% |
| Max Drawdown | -53% |
| Market Capitalization | 5.2B CNY |
| Shares Outstanding | 532 774 016 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Chenguang Biotech Group Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Chenguang Biotech Group Co., Ltd. engages in natural plant extractions. The company is headquartered in Handan, Hebei and currently employs 1,757 full-time employees. The company went IPO on 2010-11-05. The Company’s products include pigment, spices, supplement and medicine products, cottonseed products and others. The firm distributes its products in domestic and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one
Chenguang Biotech Group Co Ltd
stock under the Base Case scenario is
23.89
CNY.
Compared to the current market price of 9.77 CNY,
Chenguang Biotech Group Co Ltd
is
Undervalued by 59%.
You don't have any saved screeners yet
